A Case Report of Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment in Resource‐Limited Setup: An Ethiopian Experience
Open Access
- 7 February 2025
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70180
Abstract
MOSD is a rare and disabling immune‐mediated inflammatory Astrocytopathic disease characterized by demyelination and axonal destruction, typically involving the spinal cord and the optic nerve. Here we present a case report of a 53‐year‐old female patient who had a pertinent history of treatment for optic neuritis a few months back, currently diagnosed with Neuromyelitis Optica after she presented with a three‐week history of weakness of lower extremity, headache, and neuropathic pain. She was pulsed with methylprednisolone and started on azathioprine, which significantly improved her clinical condition. When patients with optic neuritis and transverse myelitis occur, a high index of suspicion for NMOSD is essential. Establishing a diagnosis based on clinical and MRI findings is crucial for initiating therapy quickly, halting more harm, and avoiding a delay in diagnosis. Our experience treating our patient shows that Azathioprine is still a practical choice in resource‐limited setups.Keywords
All Related Versions
This publication has 21 references indexed in Scilit:
- Prognostic value of endotoxin activity assay in patients with severe sepsis after cardiac surgeryJournal of Inflammation, 2013
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodiesJournal of Neurology, Neurosurgery & Psychiatry, 2013
- Clinical spectrum of CNS aquaporin-4 autoimmunityNeurology, 2012
- AzathioprineNeurology, 2011
- EFNS guidelines on diagnosis and management of neuromyelitis opticaEuropean Journal of Neurology, 2010
- Treatment of Neuromyelitis Optica With Mycophenolate MofetilArchives of Neurology, 2009
- Neuromyelitis Optica IgG Serostatus in Fulminant Central Nervous System Inflammatory Demyelinating DiseaseArchives of Neurology, 2009
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelJournal of Experimental Medicine, 2005
- The clinical course of neuromyelitis optica (Devic’s syndrome)Neurology, 1999